JPMORGAN CHASE & CO - 30 Apr 2025 SCHEDULE 13G/A Report for ALTERITY THERAPEUTICS LIMITED American Depositary Shares, each representing 600 Ordinary Shares (ATHE)

Filing Manager: JPMORGAN CHASE & CO
Reporting Manager: JPMORGAN CHASE & CO.
Security: ALTERITY THERAPEUTICS LIMITED American Depositary Shares, each representing 600 Ordinary Shares
Symbol: ATHE
Shares outstanding: 9,150,873,425 shares
Disclosed Ownership: 366,034,937 shares
Ownership: 4%
Form type: SCHEDULE 13G/A
Filing time: 05 May 2025, 14:03:05 UTC
Date of event: 30 Apr 2025
Previous filing: 02 May 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JPMORGAN CHASE & CO.	4%	366,034,937	366,034,937	0	Rachel Tsvaygoft	Vice President